About this trial
Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare this to the microbiome of age and sex matched controls. The investigators aim to answer the question whether the gut and skin microbiome of patients with vitiligo differs from the general population.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients with and/or without vitiligo lesional expansion over the past year.
Age/sex-matched controls who do not have a diagnosis of vitiligo
Subjects who are age 18-89 years of age at time of enrollment
Subjects who are able and willing to give informed consent for this study and the Dermatology Tissue Acquisition and Biorepository (STU00009443)
Disqualifiers
Subjects who are younger than 18 years of age or 90 years of age or older
Subjects who are unable to give consent
Trial population
Adults with or without vitiligo who are under the age of 90 years old.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Microbiome composition
Diversity analysis of microbiome samples in control subjects versus vitiligo subjects (measured by number of bacteria species/sample)
Disease Progression
Disease progression in control subjects versus vitiligo subjects (measured by VASI score (0-100)).
Secondary outcomes
Diet History Food Frequencies
Scoring from diet history food frequency questionnaires (measured by average daily food frequency scores).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.